Justine Decroocq Selected Research

Justine Decroocq Research Topics

10	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2023 - 09/2015
4	Neoplasms (Cancer) 11/2023 - 09/2015
2	Hematologic Neoplasms (Hematological Malignancy) 10/2022 - 01/2022
1	Lymphoma (Lymphomas) 08/2023
1	Hodgkin Disease (Hodgkin's Disease) 08/2023
1	Hyperkalemia 08/2023
1	COVID-19 10/2022
1	Multiple Myeloma 10/2022
1	Oncogene Addiction 01/2022
1	Leukemia 01/2022
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022
1	Critical Illness (Critically Ill) 01/2022
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2022
1	Philadelphia Chromosome 12/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2021
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 08/2014
1	Diarrhea 05/2014
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 05/2014
1	Caliciviridae Infections 05/2014

2	Chimeric Antigen ReceptorsIBA 11/2023 - 08/2023
1	Azacitidine (5 Azacytidine)FDA Link 10/2023
1	Hemoglobins (Hemoglobin)IBA 08/2023
1	Immune Checkpoint InhibitorsIBA 08/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2022
1	olaparibIBA 12/2022
1	Monoclonal AntibodiesIBA 10/2022
1	Agammaglobulinaemia Tyrosine KinaseIBA 10/2022
1	COVID-19 VaccinesIBA 10/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	eprenetapoptIBA 01/2022
1	trametinibIBA 01/2022
1	Etoposide (VP 16)FDA LinkGeneric 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	GSK621IBA 01/2022
1	ponatinibIBA 12/2021
1	asciminibIBA 12/2021
1	Vitamin D FDA LinkGeneric 01/2020
1	Antimitotic AgentsIBA 01/2020
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2020
1	fludarabineIBA 01/2019
1	Glutamine (L-Glutamine)FDA Link 09/2015
1	Tyrosine Kinase InhibitorsIBA 09/2015
1	fms-Like Tyrosine Kinase 3IBA 09/2015
1	proto-oncogene proteins pimIBA 09/2015
1	romiplostim FDA Link 08/2014
1	Thrombopoietin ReceptorsIBA 08/2014
1	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2014
1	Immunoglobulins (Immunoglobulin)IBA 05/2014
1	Alemtuzumab (Campath)FDA Link 05/2014